Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Prasinotech is a Greek biotechnology company specializing in the cultivation of microalgae and the extraction of high-value bioactive compounds for the cosmetic, nutraceutical, and pharmaceutical industries. The company utilizes proprietary photobioreactor technology to produce sustainable, high-purity ingredients such as carotenoids, proteins, and fatty acids. Prasinotech focuses on developing natural alternatives to synthetic chemicals, leveraging the metabolic diversity of microalgae to address needs in skin protection, anti-aging, and nutritional supplementation. Their business model encompasses both the supply of raw materials and the development of proprietary formulations. The company is actively involved in research and development to expand the applications of algal biomass in life sciences.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Prasinotech.